Inhibition of PDEδ by deltarasin in human KRAS-mutant pancreatic cancer cell lines blocks the localization of KRAS to the plasma membrane and impairs their proliferative capacity [69]. The gene discussed is KRAS; the disease is pancreatic neoplasm.